IL6 and breast cancer: Deregulated overexpression of IL-6 induces cell proliferation, EMT, stem cell phenotype, angiogenesis, metastasis, cachexia, self-renewal of cancer stem cells, and therapeutic resistance in breast cancer [19–23].